Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Off-label Drug Use Increases Risk of Adverse Events in Adults: Study November 6, 2015 Irvin Jackson Add Your Comments The findings of a new study appear to confirm worries that federal regulators have held for decades, indicating that use of prescription drugs for unapproved indications increases the risk of harmful side effects. A group of Canadian researchers say that doctors who prescribe drugs to patients for uses that are not approved by the health regulators as safe and effective may place individuals at a 44% increased risk of suffering an adverse drug event. The findings were published in the medical journal JAMA Internal Medicine on November 2. The results appear to back up long-held policies by the FDA in the U.S., which has banned drug companies from promoting their products for unapproved uses, known as “off-label” marketing. While it is legal for doctors to prescribe drugs for any purpose they see fit, drug companies are prohibited from promoting such unapproved uses until they provide sufficient evidence to establish that it is safe and effective. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION When drug makers engage in “off-label” drug marketing they have faced large fines and penalties, but the industry has recently been pushing back against the ban, arguing that it violates their First Amendment freedom of speech rights. The study’s findings may provide strong support for the continued enforcement of the ban, highlighting the serious risks consumers may face if drug makers are able to promote off-label drug use without conducting sufficient studies and research. Consumers May Face Risks from Untested Off-Label Uses Researchers looked at data on 46,021 patients who received 151,305 drug prescriptions in Quebec, Canada. They then determined which prescriptions were given for off-label uses, and which off-label uses were, or were not, backed up by scientific evidence. The study then followed up on those patients until the end of treatment, until the drug was discontinued, or until the end of follow up, which went from January 1, 2005 through December 30, 2010. According to the findings, the rate of adverse drug events for off-label use was overall 19.7 per 10,000 person-months. That compares to a rate of 12.5 for on-label use, meaning off-label use resulted in a 44% higher risk of harmful side effects. When researchers looked at those off-label uses backed by science, but not yet approved by Health Canada, that country’s medical and health regulatory agency, there was little difference in the rate of adverse events. However, off-label uses that were not backed up by science were 54% more likely to result in adverse drug events. Strong scientific evidence for off-label use was present only 20% of the time. Off-Label Drug Marketing In August, a federal judge issued a preliminary injunction which prevents the FDA from enforcing its off-label promotion restrictions on Amarin Pharma, which wants to promote its fish oil products for uses that the FDA has not deemed safe or effective. The FDA warned the judge that blocking its ability to regulate advertising by drug manufacturers will pose a serious public health risk. However, the judge said the FDA’s off-label marketing rule may be unconstitutional, referencing recent decisions that give corporations increased speech rights. The ruling only currently applies to Amarin. An accompanying editorial by Drs. Chester B. Good and Walid F. Gellad, with the U.S. Department of Veterans Affairs and the University of Pittsburgh, notes that the study’s findings, the most comprehensive yet to date, appears to back up the FDA’s premise that promoting unproven drugs for unapproved uses is dangerous for patients. “Critics of off-label drug promotion point to dietary supplements as an example of the kinds of claims that are commonplace when regulation is lax and worry about an erosion of the authority of the FDA to ensure safety and efficacy of drugs,” they wrote. “Are these concerns about safety warranted? Does evidence show that off-label prescribing might be less safe than on-label prescribing? In light of these concerns, the study of off-label drug use and adverse drug events…is particularly timely.” In recent years, the FDA has cracked down on a number of major drug companies for off-label promotion violations. In November 2013, Johnson & Johnson agreed to pay $2.2 billion to the federal government to settle its Risperdal illegal marketing claims. Investigators say that the illegal marketing led to the unnecessary and risky use of drugs like Risperdal, which is sometimes used in nursing homes as a form of chemical restraint, potentially putting dementia patients’ lives at risk. The DOJ began investigating Johnson & Johnson’s marketing of Risperdal in 2004, looking into an alleged kickback scheme between the drug maker and Omnicare, the nation’s largest provider of drugs to nursing homes. Although federal drug regualtors and other safety officials have been working to reduce the use of antipsychotics in nursing home patients, indicating that the drugs carry little benefit for dementia patients and may increase the risk of death, widespread overuse of the medications continues to be a problem following years of illegal marketing. Off-label use of the anti-nausea drug Zofran has also been a concern in recent years, after GlaxoSmithKline was charged with off-label drug promotion several years ago. Promoting Zofran for pregnancy-related morning sickness was among the claims that led to a $3 billion settlement with the federal government, as the drug maker never conducted any studies to establish that Zofran use while pregnant was safe for unborn children. The company now faces a growing number of Zofran lawsuits from women who gave birth to children who suffered congenital heart problems, cleft palate, cleft lip and other birth defects. Critics point out that, for those children, the penalties against GlaxoSmithKline came too late and many doctors are still unaware of Zofran pregnancy risks. Tags: Drug Side Effects, Off-Label Marketing, Risperdal, Zofran More Lawsuit Stories Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool June 12, 2025 Facebook Class Action Lawsuit Claims Android Users’ Profiles Secretly Linked to Browsing Data June 12, 2025 E-Scooters Pose Serious Risks to Teens Under 16 Years Old: Study June 12, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025) Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025) Tepezza Tinnitus and Hearing Loss Lawsuits Move Into Expert Discovery Phase (Posted: yesterday) Four Tepezza tinnitus and hearing loss lawsuits continue to be prepared for early trial dates next year, as plaintiffs’ lawyers submit case-specific expert reports this week. MORE ABOUT: TEPEZZA HEARING LOSS LAWSUITTepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today (03/31/2025)Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 (03/25/2025)Court Identifies 4 Tepezza Lawsuits Over Hearing Loss for Early Bellwether Trials (02/11/2025)
Facebook Class Action Lawsuit Claims Android Users’ Profiles Secretly Linked to Browsing Data June 12, 2025
Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)
Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)
Tepezza Tinnitus and Hearing Loss Lawsuits Move Into Expert Discovery Phase (Posted: yesterday) Four Tepezza tinnitus and hearing loss lawsuits continue to be prepared for early trial dates next year, as plaintiffs’ lawyers submit case-specific expert reports this week. MORE ABOUT: TEPEZZA HEARING LOSS LAWSUITTepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today (03/31/2025)Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 (03/25/2025)Court Identifies 4 Tepezza Lawsuits Over Hearing Loss for Early Bellwether Trials (02/11/2025)